Search Results - "Meroni, PL"

Venous thromboembolism in the antiphospholipid syndrome: management guidelines for secondary prophylaxis.

Authors: Meroni, PL Moia, M Derksen, RHWM et al.

Source: Lupus. 2003, Vol. 12 Issue 7, p504. 4p.

Mosaic of anti-endothelial antibodies.

Authors: Meroni, PL Khamashta, MA Youinou, P. et al.

Source: Lupus. Apr1995, Vol. 4 Issue 2, p95-99. 5p.

Obstetric and vascular APS: Same autoantibodies but different diseases?

Authors: Meroni, PL Raschi, E Grossi, C et al.

Source: Lupus. Jul2012, Vol. 21 Issue 7, p708-710. 3p.

Modulation of endothelial cell function by antiphospholipid antibodies.

Authors: Meroni, PL Papa, N Del Beltrami, B et al.

Source: Lupus. Oct1996, Vol. 5 Issue 5, p448-450. 3p.

Neonatal lupus and a seronegative mother.

Authors: Gattorno M Di Rocco M Buoncompagni A et al.

Source: Lancet. 3/27/2004, Vol. 363 Issue 9414, p1038-1038. 1p.

Review : β2-Glycoprotein I as a 'Cofactor' for anti-phospholipid reactivity with endothelial cells.

Authors: Meroni, PL Del Papa, N. Raschi, E. et al.

Source: Lupus. Feb1998 Supplement, Vol. 7 Issue 2S, pS44-S47. 1p.

New oral anticoagulants in thrombotic antiphospholipid syndrome.

Authors: Chighizola, CB Moia, M Meroni, PL

Source: Lupus. Oct2014, Vol. 23 Issue 12, p1279-1282. 4p.

Recent advances in antiphospholipid antibodies and antiphospholipid syndromes in pediatric populations.

Authors: Avčin, T Cimaz, R Meroni, PL

Source: Lupus. 2002, Vol. 11 Issue 1, p4-10. 7p.

Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry.

Authors: Avcin T Cimaz R Silverman ED et al.

Source: Pediatrics. Nov2008, Vol. 122 Issue 5, pe1100-7. 1p.

Vitamin D and antiphospholipid syndrome.

Authors: Andreoli, L Piantoni, S Dall’Ara, F et al.

Source: Lupus. Jul2012, Vol. 21 Issue 7, p736-740. 5p.

Prolactin’s role in the pathogenesis of the antiphospholipid syndrome.

Authors: Praprotnik, S. Agmon-Levin, N. Porat-Katz, BS et al.

Source: Lupus. 11/15/2010, Vol. 19 Issue 13, p1515-1519. 5p.

Hand impairment in systemic sclerosis: association of different hand indices with organ involvement.

Authors: Ingegnoli, F Boracchi, P Ambrogi, F et al.

Source: Scandinavian Journal of Rheumatology. Sep/Oct2010, Vol. 39 Issue 5, p393-397. 5p. 1 Chart, 2 Graphs.

Post-partum dilated cardiomyopathy in anti-phospholipid positive woman.

Authors: Airoldi, ML Eid, O. Tosetto, C. et al.

Source: Lupus. Jun1996, Vol. 5 Issue 3, p247-250. 4p.

In vitro type-1 and type-2 cytokine production in systemic lupus erythematosus: lack of relationship with clinical disease activity.

Authors: Barcellini, W. Rizzardi, GP Borghi, MO et al.

Source: Lupus. Apr1996, Vol. 5 Issue 2, p139-145. 7p.

International standards for IgG and IgM anti-β2glycoprotein antibody measurement.

Authors: Willis, R Grossi, C Orietta Borghi, M et al.

Source: Lupus. Oct2014, Vol. 23 Issue 12, p1317-1319. 3p.

Toll-like receptor 4 and β2 glycoprotein I interaction on endothelial cells.

Authors: Borghi, MO Raschi, E Grossi, C et al.

Source: Lupus. Oct2014, Vol. 23 Issue 12, p1302-1304. 3p.

Autoantibody profiling in APS.

Authors: Roggenbuck, D Somma, V Schierack, P et al.

Source: Lupus. Oct2014, Vol. 23 Issue 12, p1262-1264. 3p.

Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.

Authors: Jesús, GR Sciascia, S Andrade, D et al.

Source: BJOG: An International Journal of Obstetrics & Gynaecology. Apr2019, Vol. 126 Issue 5, p656-661. 6p. 1 Chart, 1 Graph.

Decreased expression of heparin-binding epidermal growth factor-like growth factor as a newly identified pathogenic mechanism of antiphospholipid-mediated defective placentation.

Authors: Di Simone N Marana R Castellani R et al.

Source: Arthritis & Rheumatism. May2010, Vol. 62 Issue 5, p1504-1512. 9p.

A novel autoantigen to differentiate limited cutaneous systemic sclerosis from diffuse cutaneous systemic sclerosis: The interferon-inducible gene IFI16.

Authors: Mondini M Vidali M Andrea MD et al.

Source: Arthritis & Rheumatism. Dec2006, Vol. 54 Issue 12, p3939-3944. 6p.